Add another Item to this comparison
Add Item
| Basic Medical Informatin |
| brand name |
|
Celexa |
vs |
Namenda, Namenda Xr |
|
| Treatment For |
|
Depression |
vs |
Moderate To Severe Dementia Of The Alzheimer's Type |
|
| Legal Status |
|
Rx-only |
vs |
Rx-only |
|
| Pregnancy cat. |
|
C (us) |
vs |
B (us) |
|
| Possible Side Effects |
|
Headache With Chest Pain And Severe Dizziness, Fainting, Palpitation, Nausea, Vomiting, Diarrhea, Loss Of Appetite, Dry Mouth, Weight Loss |
vs |
|
|
| Precautions & Contraindications |
|
Seizures Or Liver, Kidney, Or Heart Disease, Qt Prolongation, Pregnancy And Breastfeeding |
vs |
Epilepsy Or Other Seizure Disorder; Cataracts; Liver Disease; Kidney Disease; Bladder Or Kidney Infection |
|
| Excretion |
|
Mostly As Unmetabolized Citalopram, Partly Dct And Traces Of Ddct In Urine |
vs |
Renal |
|
| Storage Conditions |
|
25°c, In Airtight Container And Keep Away From Children |
vs |
25°c, In An Airtight Container, Keep Away From Children |
|
| Dosage, Usage and Forms |
| Forms |
|
Tablet |
vs |
Tablet |
|
| Routes (of administration) |
|
Oral |
vs |
Oral |
|
|
Dosage |
|
20 mg |
vs |
5 mg (5 mg (Namenda), 7 mg (Namenda XR)) |
|
| Chemical Data |
| Bioavailability |
|
80%, Peak At 4 Hours |
vs |
100 % |
|
| Protein binding |
|
|
vs |
Hepatic ( |
|
| Metabolism |
|
Hepatic |
vs |
|
|
| Half Life (hours) |
|
35 h |
vs |
60-100 H |
|
| Formula |
|
C20h21fn2o |
vs |
C12h21n |
|
| Molecular mass (g/mol) |
|
324.392 G/mol |
vs |
179.3 G/mol |
|
Compare Citalopram vs Memantine Alzheimer's Medications
Add Comment about “brand name”
Add Comment about “
cancel